UnitedHealth Group Inc $ 303.23 0.73 (0.24%)
Volume:
2,500,384
Avg Vol (1m):
2,768,822
Market Cap $:
288.17 Bil
Enterprise Value $:
311.53 Bil
P/E (TTM):
17.04
P/B:
4.53
Financial Strength | 6/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.56 | ||
| Equity-to-Asset | 0.33 | ||
| Debt-to-Equity | 0.72 | ||
| Debt-to-EBITDA | 1.69 | ||
| Interest Coverage | 12.97 | ||
| Piotroski F-Score | 7 | ||
| Altman Z-Score | 3.49 | ||
| WACC vs ROIC | |||
Profitability Rank | 9/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 9.24 | ||
| Net Margin % | 6.94 | ||
| ROE % | 29.86 | ||
| ROA % | 9.54 | ||
| ROC (Joel Greenblatt) % | 288.56 | ||
| 3-Year Revenue Growth Rate | 9.4 | ||
| 3-Year EBITDA Growth Rate | 14.4 | ||
| 3-Year EPS without NRI Growth Rate | 25.5 |
Valuation Rank | 2/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 17.04 | ||
| Forward PE Ratio | 16.48 | ||
| PE Ratio without NRI | 17.04 | ||
| Price-to-Owner-Earnings | 15.03 | ||
| PB Ratio | 4.53 | ||
| PS Ratio | 1.19 | ||
| Price-to-Free-Cash-Flow | 14.38 | ||
| Price-to-Operating-Cash-Flow | 13.08 | ||
| EV-to-EBIT | 12.81 | ||
| EV-to-EBITDA | 11.43 | ||
| EV-to-Revenue | 1.27 | ||
| PEG Ratio | 1.17 | ||
| Shiller PE Ratio | 33.9 | ||
| Current Ratio | 0.84 | ||
| Quick Ratio | 0.84 | ||
| Days Sales Outstanding | 18.6 | ||
| Days Payable | 89.33 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Dividend Yield % | 1.53 | ||
| Dividend Payout Ratio | 0.25 | ||
| 3-Year Dividend Growth Rate | 20.3 | ||
| Forward Dividend Yield % | 1.63 | ||
| 5-Year Yield-on-Cost % | 4.41 | ||
| 3-Year Average Share Buyback Ratio | 0.1 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | -9223372036854776 | ||
| Price-to-Intrinsic-Value-Projected-FCF | 1.23 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 0.86 | ||
| Price-to-Median-PS-Value | 1.5 | ||
| Price-to-Peter-Lynch-Fair-Value | 1.12 | ||
| Earnings Yield (Greenblatt) % | 7.81 | ||
| Forward Rate of Return (Yacktman) % | 19.63 |